Company intelligence / Profile preview

Neomedica

Ownership: Private
Employees: ~81
Development stage: Commercial

Overview

Neomedica develops and manufactures a broad portfolio of in vitro diagnostic medical devices for use in clinical laboratories worldwide. Their product lines include systems for clinical chemistry, hematology, immunology, urinalysis, point-of-care testing (POC), and veterinary diagnostics. The company emphasizes high automation and quality standards in its manufacturing processes[1][2].

Modalities: Diagnostic device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Neomedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neomedica.

Explore the full profile